Brief: Ryvu Therapeutics Q1 Net Loss Widens To 13.6 Mln Zlotys
May 12 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q1 NET LOSS 13.6 MILLION ZLOTYS VERSUS LOSS OF 4.3 MILLION
ZLOTYS YEAR AGO
* Q1 REVENUE FROM SALES 0.4 MILLION ZLOTYS VERSUS 7.8
MILLION
ZLOTYS YEAR AGO
* Q1 OPERATING LOSS 15.7 MILLION ZLOTYS VERSUS LOSS OF 5.0
MILLION
ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM5KjjHsa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project